TANAKA Contributes to Ambix Life Science Fund, a U.S. Medical Device Venture Fund
(Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which is a subsidiary of TANAKA Holdings Co., Ltd. and operates the TANAKA Precious Metals manufacturing business, announced today that TANAKA made an equity contribution to Ambix Life Science Fund I, L.P., a medical device venture fund managed by Ambix Venture Management, LLC, a U.S.-based venture capital management company ("Ambix Ventures").
- (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which is a subsidiary of TANAKA Holdings Co., Ltd. and operates the TANAKA Precious Metals manufacturing business, announced today that TANAKA made an equity contribution to Ambix Life Science Fund I, L.P., a medical device venture fund managed by Ambix Venture Management, LLC, a U.S.-based venture capital management company ("Ambix Ventures").
- TANAKA provides precious metal components and materials to medical device manufacturers and participates in development projects, cooperating with and contributing to development in the healthcare field.
- About Ambix Life Science Fund and Aaron Berez, MD
Ambix Life Science Fund I, L.P. is a medical device venture fund managed by Ambix Venture Management, LLC, a U.S.-based venture capital management company. - Overview of Ambix Life Science Fund I, L.P.
Fund name: Ambix Life Science Fund I, L.P., a Delaware limited partnership
The fund is a relatively new fund based around a long-standing syndicate of medical device investors.